Childhood/AYA Cancer
NCCN Publishes Guidelines for Pediatric Solid Tumor
February 22, 2021
Article
The National Comprehensive Cancer Network has issued guidelines for the management of children with a rare type of kidney cancer referred to as Wilms Tumor, or nephroblastoma.
COVID-19 Misinformation: Parents of Patients May Fall for It
February 18, 2021
Article
Parents of pediatric patients with cancer were more likely to believe COVID-19 misinformation than parents of children without cancer.
FDA Approves Crizotinib for Pediatric/Young Adult ALK+ Anaplastic Large Cell Lymphoma
January 15, 2021
Article
The FDA has approved crizotinib (Xalkori) for the treatment of pediatric patients 1 year of age and older and young adults with ALK-positive relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL).
Genetic Precursors to Pediatric Rhabdomyosarcoma Identified
January 07, 2021
Article
“But our study is pointing to new genes to consider. For example, we found that the BRCA2 gene, typically associated with adult breast and ovarian cancer, may also somehow influence the susceptibility of pediatric RMS.”
FDA Approves Pralsetinib for RET-Altered Thyroid Cancers
December 02, 2020
Article
The FDA approved pralsetinib (Gavreto) for adults and children aged 12 or older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who need systemic therapy or RET fusion-positive thyroid cancer who require systemic therapy and are radioactive iodine-refractory.
FDA Approves Naxitamab-gqgk for Pediatric and Adult High-Risk Neuroblastoma
November 26, 2020
Article
The FDA has granted an accelerated approval to naxitamab-gqgk (Danyelza) for use in combination with granulocyte-macrophage colony-stimulating factor as a treatment for pediatric patients 1 year of age and older and adult patients with relapsed/refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior treatment.
Capturing the Voice of the Child in Cancer Care
October 30, 2020
Podcast
From compassionate listening to syringe water fights, children shared some creative ways that nurses have managed to make their care a bit less scary.
A Smiling Nurse Makes All the Difference in Pediatric Oncology
October 23, 2020
Article
Being hospitalized for cancer can be a frightening experience for a child, but a friendly and approachable nurse can make all the difference.
Pediatric Osteosarcoma and Pathogenic TP53 Variants
October 19, 2020
Article
TP53 was found to be the only gene with a germline de novo pathogenic or likely pathogenic variant in pediatric patients with osteosarcoma, according to findings from the Children’s Oncology Group that were published in JCO Precision Oncology.